Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 2Phase 4 2Phase 2/3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Prostatic Hyperplasia 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Finasteride × Clear all
NCT06001619 2023-08-21

PROMED

Turku University Hospital

Phase 4 Recruiting
100 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

NCT01296672 2017-10-06

3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer

The University of Texas Health Science Center at San Antonio

Phase 4 Completed
383 enrolled 9 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡